TISATO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 3.453
NA - Nord America 1.156
SA - Sud America 748
EU - Europa 290
AF - Africa 76
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.729
Nazione #
SG - Singapore 1.490
US - Stati Uniti d'America 1.063
CN - Cina 746
BR - Brasile 625
HK - Hong Kong 441
VN - Vietnam 311
KR - Corea 201
IN - India 57
GB - Regno Unito 54
AR - Argentina 49
CA - Canada 37
IT - Italia 34
DE - Germania 33
JP - Giappone 28
FR - Francia 27
FI - Finlandia 26
IL - Israele 25
BD - Bangladesh 24
MX - Messico 23
NL - Olanda 22
ID - Indonesia 20
EC - Ecuador 18
ZA - Sudafrica 18
PY - Paraguay 14
TN - Tunisia 14
IQ - Iraq 13
BE - Belgio 12
IR - Iran 12
PK - Pakistan 11
RU - Federazione Russa 11
AZ - Azerbaigian 10
CO - Colombia 10
EG - Egitto 10
VE - Venezuela 10
ES - Italia 9
UZ - Uzbekistan 9
MA - Marocco 8
PE - Perù 8
TR - Turchia 8
UA - Ucraina 8
CL - Cile 7
PL - Polonia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
PA - Panama 6
AL - Albania 5
AT - Austria 5
KE - Kenya 5
SA - Arabia Saudita 5
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
PH - Filippine 4
SI - Slovenia 4
SN - Senegal 4
CH - Svizzera 3
CI - Costa d'Avorio 3
DZ - Algeria 3
KW - Kuwait 3
LT - Lituania 3
MK - Macedonia 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
SE - Svezia 3
TT - Trinidad e Tobago 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CD - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GN - Guinea 1
HU - Ungheria 1
IE - Irlanda 1
LB - Libano 1
ME - Montenegro 1
ML - Mali 1
Totale 5.716
Città #
Singapore 950
Santa Clara 513
Hefei 453
Hong Kong 440
Seoul 198
Beijing 112
Ho Chi Minh City 111
Hanoi 66
Dallas 65
San Jose 61
Ashburn 54
Los Angeles 44
São Paulo 41
Guangzhou 33
Rio de Janeiro 28
Minamishinagawa 24
Helsinki 22
Bengaluru 17
Buffalo 17
Belo Horizonte 15
Frankfurt am Main 15
New York 14
Toronto 13
Brussels 12
Biên Hòa 11
Haiphong 11
London 11
Tehran 10
Baku 9
Brasília 9
Campinas 9
Curitiba 9
Da Nang 8
Dhaka 8
Porto Alegre 8
Tashkent 8
Atlanta 7
Brooklyn 7
Johannesburg 7
Lauterbourg 7
Manaus 7
Ottawa 7
Phoenix 7
Quito 7
São José dos Campos 7
Uberlândia 7
Asunción 6
Can Tho 6
Contagem 6
Nam Định 6
New Delhi 6
Quận Một 6
Ribeirão Preto 6
Athens 5
Bình Dương 5
Cape Town 5
Chicago 5
Erbil 5
Lima 5
Lấp Vò 5
Ninh Bình 5
Orem 5
Padua 5
Philadelphia 5
Poços de Caldas 5
Quảng Ninh 5
Salvador 5
São Carlos 5
Thái Nguyên 5
Warsaw 5
Amman 4
Aracaju 4
Berlin 4
Buenos Aires 4
Camaçari 4
Ciudad del Este 4
Dakar 4
Goiânia 4
Gravataí 4
Ha Long 4
Hải Dương 4
Montevideo 4
Moscow 4
Nairobi 4
Panama City 4
Phủ Lý 4
Piracicaba 4
Portsmouth 4
San Francisco 4
Tirana 4
Tunis 4
Volta Redonda 4
Abidjan 3
Barbacena 3
Barueri 3
Bauru 3
Bắc Giang 3
Cairo 3
Campo Grande 3
Canoas 3
Totale 3.738
Nome #
Copper(I) and copper(II) adducts detected under ESI-MS conditions during the study of cytotoxic phosphino Cu(I) complexes. 76
Phthalates and heavy metals as endocrine disruptors in food: A study on pre-packed coffee products 68
Synthesis and characterization of novel 99-technetium(III) phosphine complexes. HPLC characterization and rat biodistribution of the Tc-99m analogs 68
Technetium(V) and rhenium(V) complexes with Schiff-base ligands containing the ONNNO donor atom set. Crystal structure of [N,N?-3-azapentane-1,5-diylbis(salicylideneiminato)(3-)-O,O',N, N',N'']-oxotechnetium(V) 65
From phosphines to water soluble carbenes: synthesis and biological investigation of 11th group metal complexes 64
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 62
Relationship Between ESI(+)-MS Behavior and Cytotoxic Activity of [MI(P)4]+-type Complexes (M = Cu, Ag, Au; P = Tertiary Phosphane)" 58
New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity 57
Synthesis and characterization of the bis(trithioperoxybenzoate) (dithiobenzoate) rhenium( III) hetero complex 56
Synthesis, characterization and crystal structure of oxobis(p-thiocresolato)terpyridinerhenium(V), a new cationic, six-coordinate thiolato complex of rhenium 53
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 53
Reactivity of Al(III) with membrane phospholipids: A NMR approach 50
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 48
Experimental Evidences of The Presence of Bimolecular Caffeine/Catechin Complexes in Green Tea Extracts 48
Gold nanorods - copper(I) complexes conjugates as anticancer drug-delivery system 47
ESI-MSn study of the interaction products of cytotoxic phosphino copper(I) complexes with model peptides 45
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 45
Structure of [Cu(DAPTA)4]+ complex in extremely diluted aqueous solution 45
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 44
Syntheses and characterization of new rhenium(V)-oxo complexes containing N,N,O-heteroscorpionate ligands 43
Copper(I) heteroleptic 3+1 complexes: ligand effect on their in vitro cytotoxicity 43
Metabolomic fingerprinting of plant extracts 43
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase 40
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 40
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 39
Radioactive Transition Metal Nitride Hetero-Complex 39
Evidence of non-covalent complexes in some natural extracts: Ceylon tea and Mate extracts 39
From tetrahedrical homoleptic phosphino copper (I) complexes [CuP4]+ to low coordinated species: effect on the antiproliferative activity 39
Synthesis, reactivity and cytotoxic properties of water soluble coinage metal N-Heterocyclic Carbene complexes 38
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 37
Synthesis and Characterization of Mixed-Ligand Zn(II) and Cu(II) Complexes Including Polyamines and Dicyano-dithiolate(2-): In vitro Cytotoxic Activity of Cu(II) Compounds 37
Interaction products of cytotoxic Cu(I) complexes with different solvent mixtures: an electrospray ionization mass spectrometry and density functional theory study 36
Coordinative unsaturated CuI entities are crucial intermediates governing cell internalization of copper. A combined experimental ESI-MS and DFT study. 36
Neutral and charged copper(I) complexes on hydrophilic gold nanoparticles and nanorods: loading and structural studies for biomedical applications 36
Phosphino copper(I) complexes as potential anticancer agents: physico-chemical and biological properties 36
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 35
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 35
[MI(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper "3+1" mixed-ligand compounds 35
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 35
Electrospray ionization in the study of the interactions between cytotoxic phosphino Cu(i) complexes and selected amino acids and GlyGlyHis peptide model 35
Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications 35
Synthesis and characterization of novel tetrahedral copper(I) complexes comprising tridentate PNP-aminodiphosphines and tetradentate PN(X)P-substituted aminodiphosphines (X = O, S) 35
Phosphanyl-amino complexes of nickel(II): Synthesis and structure 33
Contamination of dry foods with trimethyldiphenylmethanes by migration from recycled paper and board packaging 33
Copper(I) complexes with phosphines P(p-OCH3-Ph)2CH2OH and P(p-OCH3-Ph)2CH2SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitroantiproliferative activity 33
Electrospray ionization study of tricarbonyl fac-[Re(CO)3(PO)(X)]- type complexes: influence of ancillary co-ligands in the release of carbon monoxide 33
Cu(I) Complexes Bearing Phosphines Derived From Hydrophilic SarGly -Physicochemical and Biological Characteristics 33
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 32
Copper in Diseases and Treatments, and Copper-Based Anticancer Strategies 32
Synthesis and characterization of mixed-ligand Zn(II) and Cu(II) complexes including polyamines and dicyanodithiolate: in vitro cytotoxic activity of Cu(II) compounds 32
In vitro evaluation of antileishmanial activity of copper (I) complexes 32
Synthesis, Characterization and Crystal Structure of the Water Soluble Copper(I) Complex with Trisulfonated Triphenylphosphine 32
Phosphine-copper(I) complexes as anticancer agents: design, synthesis, and physicochemical characterization. Part I 32
ESI-MSn study of the interaction products of a cytotoxic phosphino copper(I) complex with methionine-rich peptides 32
Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides 32
Copper Complexes as Anticancer Agents 32
Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance 31
On the presence of non-covalent complexes in natural extracts 31
Synthesis and characterization of Oxorhenium(V) Complexes Containing o-diphenylphosphinophenolato and monothiolato lingands 30
[Cu(thp)4]n[X]-n compounds for the treatment of a broad range of human solid tumors, including refractory tumors. 30
Cu(I) and Ag(I) complex formation with the hydrophilic phosphine 1, 3, 5 triaza-7-phosphadamantane in different ionic media. How to estimate the effect of a complexing medium 30
Synthesis of new copper(I) complexes with hydrophilic aminomethylphosphines 29
ESI in the study of the interactions between phosphino-Cu(I) complexes and Cu(II) salts with model peptides relevant to human copper transporters (hCTR) 29
Phosphine copper(I) complexes as anticancer agents: biological characterization. Part II 29
(2-Hydroxyphenyl)diphenylphosphine as fac-[Re/Tc-99m(CO)(3)](+)-ligand 29
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 29
In vitro antitumor activity of water-soluble copper(I) complexes with diimine and monodentate phosphine ligands 29
Evaluation of anti-Leishmania activity induced by silver metal complexes against leishmania amazonensis and leishmanial guyanensis 28
Low-Valent Technetium Complexes with Aminodiphosphines 28
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): Cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands 28
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 27
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 27
A NEW PHASE OF BIS[2-(DIPHENYLPHOSPHINO-K-P-PHENYLAZANIDO-K-N](ETHANOLATO)(OXO)-RHENIUM(V) 27
Hydrophilic gold nanoparticles and nanorods as drug delivery systems for anticancer copper complexes 26
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 26
Syntheses and characterization of amino and amido-imido technetium(V) and rhenium(V) complexes with (o-aminophenyl)diphenylphosphine-N,P. Crystal structures of [TcNCl{PPh2(C6H4NH2-2)} 2]Cl·MeCN and [Re{PPh2(C6H4N-2)}Cl2{PPh 2(C6H4NH-2}] 26
Neutral fac-[Re(I)/Tc-99m(I)(CO)(3)](+)-complexes with the new PO/L-donor system 26
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 26
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 25
ESI(+)MS and DFT studies on the internalization of copper in tumour cells: copper(II)/copper(I) interplay at the hCtr1 substrate 25
Synthesis of a series of Cu(I) derivatives containing PTA, PTAH and mPTA ligands and evaluation of their cytotoxic activity 25
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 24
Synthetic routes to mono-N-functionalized P2N2-ligands 24
Technetium coordination chemistry; development of new backbones for 99mTc radiopharmaceuticals 24
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 24
The metal-fragment strategy for the construction of stable Tc and Re mixed-ligand compounds relevant to nuclear medicine 24
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 24
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 23
Mixed-Ligand Rhenium-188 Complexes with Tetradentate/Monodentate NS3/P ('4 + 1') Coordination: Relation of Structure with Antioxidation Stability 23
Synthesis and characterization of [dichloro[hydrotris(1-pyrazolyl)borate]sulfido-technetium(V)] and [bis-(u-ethane-1,2-dithiolato)-bis-(ethene-1,2-dithiolato)-technetium(IV)] complexes. The first evidence of a terminal Tc=S multiple bond 23
SYNTHESIS AND CHARACTERIZATION OF NEUTRAL TECHNETIUM(III) COMPLEXES WITH MIXED S,P-BIDENTATE PHOSPHINE THIOLATE LIGANDS - CRYSTAL-STRUCTURE OF [TC(SCH2CH2PPH2)2(SCH2CH2PPH2O)] 23
Syntheses and reactivity of sulphur rich Re(III) and Tc(III) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands 23
Hydrophilic gold nanoparticles and nanorods as drug delivery systems for anti cancer copper complexes 23
Rhenium(I) Tricarbonyl Complexes with (2-Hydroxyphenyl)diphenylphosphine as PO Bidentate Ligand 23
Alternative Synthesis of Aminodiphosphines 23
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 23
Synthesis of Asymmetrical Heterocomplexes of the [99mTc/99gTc(N)(PNP)]2+ Fragment with Cysteine-Functionalized Biotin 22
Neutral and cationic nickel (II) complexes of phosphino-amines: [NiCl2(PMe2Ph)(PNMe2)] and [NiCl(PMe2Ph) (PNMe2)]PF6 (PNMe2 = N,N?-dimethyl-2-(diphenylphosphino) aniline) 22
Copper(I) and copper(II) complexes of polydentate phosphinoamines 22
UNUSUAL SYNTHESIS AND X-RAY STRUCTURE OF CIS-DICHLORO[1,2-BIS(O-(DIPHENYLPHOSPHINO)PHENYL)ETHANE-1,2-DIOLATO(2-)]TECHNETIUM(IV) HEMIETHANOL SOLVATE 22
Totale 3.506
Categoria #
all - tutte 24.031
article - articoli 14.898
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 457
Totale 39.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202451 0 0 0 0 0 0 0 0 2 0 48 1
2024/20252.667 8 19 220 134 428 141 36 71 35 53 806 716
2025/20263.011 270 457 500 755 791 162 76 0 0 0 0 0
Totale 5.729